Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users.
Ann. Thorac. Surg., Jan;93(1):51-7 (2012)
Gonococcal ascending aortitis with penetrating ulcers and intraluminal thrombus.
Ann. Thorac. Surg., Mar;91(3):910-2 (2011)
Prevalence and procedural outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with diabetes and multivessel coronary artery disease.
J Card Surg., Jan;26(1):1-8 (2011)
Predictive value of the Seattle Heart Failure Model in patients undergoing left ventricular assist device placement.
J. Heart Lung Transplant., Sep;29(9):1021-5 (2010)
Changing volumes, risk profiles, and outcomes of coronary artery bypass grafting and percutaneous coronary interventions.
Ann. Thorac. Surg., Jun;87(6):1828-38 (2009)
Characteristics of extracoronary vascular disease in heart transplant recipient.
J Card Surg., 23(5):459-63 (2008 Sep-Oct)
The emerging epidemic of methamphetamine-induced aortic dissections.
J Card Surg., 22(5):390-3 (2007 Sep-Oct)
Differential expression in markers for thrombin, platelet activation, and inflammation in cell saver versus systemic blood in patients undergoing on-pump coronary artery bypass graft surgery.
J. Cardiothorac. Vasc. Anesth., Aug;21(4):519-23 (2007)
Does the type of surgery effect systemic response following cardiopulmonary bypass?
J Card Surg., 22(4):307-13 (2007 Jul-Aug)
Is pre-transplant vascular disease a risk factor for mortality and morbidity after heart transplantation?
Eur J Cardiothorac Surg., Mar;31(3):457-61 (2007)
Open-chest management after heart transplantation.
Tex Heart Inst J., 33(3):306-9 (2006)
Expectant management is safe for cholelithiasis after heart transplant.
J. Heart Lung Transplant., May;25(5):539-43 (2006)
Effects of a statewide physician-led quality-improvement program on the quality of cardiac care.
Am. Heart J., May;151(5):1033-42 (2006)
Successful management of asystole with an isolated left ventricular assist device.
J. Heart Lung Transplant., Apr;25(4):490-2 (2006)
Case 1-2006: off-pump coronary artery bypass graft surgery anticoagulation with bivalirudin: a patient with heparin-induced thrombocytopenia syndrome type II and renal failure.
J. Cardiothorac. Vasc. Anesth., Feb;20(1):106-11 (2006)
Strategies to reduce hemostatic activation during cardiopulmonary bypass.
Thromb. Res., 117(6):689-703 (2006)
Ann. Thorac. Surg., Jun;79(6):2038-9 (2005)
A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass.
Anesthesiology., Feb;102(2):276-84 (2005)
Cardiopulmonary bypass: it's not the size, it's how you use it! Review of a comprehensive blood-conservation strategy.
J Extra Corpor Technol., Sep;36(3):263-8 (2004)
Reducing hemostatic activation during cardiopulmonary bypass: a combined approach.
Anesth. Analg., May;98(5):1208-16, table of contents (2004)